Non-Squamous Non-Small Cell Lung Cancer Recruiting Phase 3 Trials for Erlotinib (DB00530)

Also known as: Non-squamous Non-small Cell Lung Cancer

DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Recruiting3 IdentifierTitlePurposeDrugs
NCT02633189Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerTreatment